<?xml version="1.0" encoding="UTF-8"?>
<p id="par0230">Data regarding the relationship between COVID-19 and chemokine dysregulation are still scanty, but are increasingly being reported. Although preliminary, the available data provided by both clinical and 
 <italic>in vitro</italic> studies suggest possible similarities between what was observed after SARS-Cov and MERS-Cov infection. Overall, an increased production of pro-inflammatory chemokines (mainly CXCL10 and CXCL8) seems to characterize also COVID-19 infection.
</p>
